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ABSTRACT 
A series of five 12-dodecanolides have been synthesised containing CF2 groups at C5, C6, 
C7, C8 and in one case a double substitution at C5 & C8, as a strategy to bias the 
conformational space accessed by these macrocycles, and to assess if the analogues may act 
as mimetics for 12-decenolide pheromones associated with the Emerald Ash Borer.  
Accordingly individual syntheses of 5,5-difluoro- 5, 6,6-difluoro- 6, 7,7-difluoro- 7, 8,8-
difluoro- 8 and 5,5,8,8-tetrafluoro- 9,  12-decanolides is outlined and X-ray structural data 
was obtained for three (5, 8 and 9) of these compounds.  The structures show clearly that the 
CF2 groups occupy ‘corner’ locations in the macrocycle consistent with their ability to bias 
accessible conformations. The fluorine containing 12-dodecanolides all generated an 
electro-antennogram response in female beetles. 
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1. Introduction  
Fluorine is rarely encountered in natural products [1] and there are no examples 
known of insect pheromones containing fluorine; its occurrence in organic chemistry is 
almost exclusively anthropogenic. In that context fluorine has been widely and successfully 
employed to improve properties and efficacy in the design of pharmaceuticals products [2] 
and it would seem reasonable by extension that the strategic incorporation of fluorine into 
insect pheromone analogues may offer prospects as a design strategy for improving the 
efficacy of pheromone analogues. Such practice has however been slow to gain traction, and 
where fluorine has been explored in this context, outcomes have been mixed and 
unpredictable [3]. Almost always the fluorine has directly replaced an aliphatic hydrogen 
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and clear cut improvements are rare [3 - 8]. This has much to do with the pheromones 
themselves already being optimal as they are highly evolved natural products and fluorine 
not being a very good hydrogen mimetic from a steric and electronic perspective.  
Differences in molecular volatility must also be anticipated with the molecular weight 
increase. Undeterred we have explored a new approach incorporating the fluorine as a 
means to limit the conformational flexibility of a macrocyclic pheromone and we report our 
synthesis and preliminary evaluation of the efficacy of a series of analogues in this paper. 
The emerald ash borer (EAB), Agrilus planipennis Fairmaire (Coleoptera: Buprestidae), is a 
wood boring beetle native to East Asia, however it has become a serious invasive pest in 
North America, causing extensive mortality to ash trees when it emerged on the continent in 
2002 [9]. Currently it has spread to 31 States in the U.S. and across five Canadian Provinces. 
Western Europe is also under threat with its recent emergence in Russia [10]. The plant 
volatiles and pheromones such as 1 - 4 which stimulate the EAB have become relevant for 
developing strategies for monitoring and control [11]. (3Z)-Dodecen-12-olide 2 was 
identified as a key antennally-active compound produced primarily by females to attract 
males [11,12]. Similarly, the non-natural stereoisomer (3E)-dodecen-12-olide 3, and the 
saturated dodecanolactone 4, also showed similar activities towards male EAB [13]. 
 
 
 
Fluorine has advantages as a hydrogen mimetic for bioactives in that it is sterically compact, 
and it does not enter into strong intermolecular interactions [14]. However the introduction 
of fluorine is never neutral. Fluorine is significantly larger than hydrogen based on van der 
Waals radii (F = 1.47Å versus H = 1.2Å) [15] and we have established that the -CF2- group 
tends to dictate corner positions when it is incorporated into aliphatic rings, and particularly 
in medium sized macrocyclic ring compounds [16]. This is a consequence of the larger size 
of fluorine over hydrogen, avoiding transannular interactions relative to hydrogen, and also 
the electronegativity of fluorine changing the hybridisation towards sp2 at the directly bound 
carbon and widening the C-CF2-C angle, often close to sp2 hybridisation [16b]. We have 
recently explored replacing one or two CH2 groups by CF2 in various macrocyclic lactones 
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such that the stereoelectronic influence of the fluorines might limit conformational 
flexibility and help provide some insight into favoured bioactive conformations of fragrance 
lactone and ketones such as muscone [17a] and musk lactones [17b,c]. We now report the 
synthesis of the CF2 containing 12-dodecanolides 5-9 (Figure 4), where the CF2 groups are 
variously positioned around the lactone ring. The fluorines should place conformational 
constraints into these molecules at different locations, as an alternative strategy to 
introducing double bonds of defined geometry such as is found in 2 and 3. Compounds 5 - 9 
underwent preliminary electroantennography (EAG) analyses, comparing the relative 
sensitivity of the fluorinated lactones to female beetles. 
 
 
 
2. Result and Discussion 
 
Synthesis: The synthesis of the 12-dodecanolide 6, was accomplished as illustrated in 
Scheme 1. Full experimental details are given in the extensive Supplementary Information. 
A key reaction involved DAST treatment of propargylic ketone 13 to generate 
difluoromethylene 14, following previously developed protocols [18]. Orthogonal 
deprotection allowed release of alcohol 15 which was oxidised to carboxylic acid 16.  
Hydrogenation then released an alcohol at the other terminus of the chain, with concomitant 
reduction of the acetylene to generate fatty acid 17, which was cyclised to generate 12-
dodecanolide 6.  The routes to analogues 7 and 8 are illustrated in Scheme 2. Their syntheses 
were accomplished in a similar manner to that described for target 6, but differed by 
manipulating the chain lengths of the aldehydes and terminal acetylenes used to generate 
propargylic alcohols 22 and 23. In order to access 12-dodecanolide 5, the protecting group 
strategy was controlled by introducing a triisopropylsilyl ether (TIPS group) [19], such that 
oxidation could be achieved at the opposite end of the chain with respect to the previous 
syntheses.  
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Scheme 1.  Preparation of 6,6-difluorododecanolactone. Reagents and conditions: a) PCC, DCM, rt, 52%; b) 
PMBO(CH2)3C≡CH, BuLi, THF, -78°C to rt, 87%; c) IBX, DMSO, rt, overnight, 80%; d) DAST, 50°C, 42%; 
e) DDQ, wet DCM, rt, 23%; f) PhI(OAc)2, TEMPO, CH3CN/H2O, 44%; g) H2, 10% Pd/C, THF, 100%; h) 
2,4,6-trichlorobenzoyl chloride, Et3N, THF, DMAP, toluene, rt, 44%. 
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Scheme 2.  Preparation of 7,7- , 8,8- and 5,5-difluorododecanolactone 7, 8, 5. Reagents and conditions: a) IBX, 
DMSO, rt, 64% for 20, 83% for 21, 92% for 24, 78% for 25; b) BnO(CH2)3C≡CH or BnO(CH2)2C≡CH, BuLi, 
THF, -78°C to rt, 60% for 22, 70% for 23; c) DAST, 50°C, 55% for 26 and 27; d) CAN, CH3CN, H2O, rt, 82% 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
5 
 
for 28, 81% for 29; e) PhI(OAc)2, TEMPO, CH3CN/H2O, 80% for both 30 and 31, 90% for 36; f) H2, 5% Pd/C, 
THF, 71% for 32 and 57% for 33; g) 2,4,6-trichlorobenzoyl chloride, Et3N, THF, DMAP, toluene, rt, 52% for 
7, 63% for 8, 32% for 5; h) triisopropylsilyl chloride, imidazole, DCM, rt, 90%; i) H2, 10% Pd/C, THF, 76%; j) 
TBAF, THF, 50°C, 79%. 
 
 
The preparation of 5,5,8,8-tetrafluorolactone 9 proved to be the most demanding synthesis 
certainly in terms of the length of the linear sequence and the route is illustrated in Scheme 3. 
The difluoromethylene groups were introduced also by DAST reaction of a propargyl ketone 
[18] in a sequential manner to generate the orthogonally protected diacetylene 47, with both 
difluoromethylene groups installed. The p-methoxybenzyl group (PMB) was removed and 
replaced by TIPS and then a key hydrogenation step, using palladium on carbon cleaved the 
terminal benzyl ether with concomitant saturation of both acetylene bonds, to generate 
aliphatic alcohol 50. An oxidation to carboxylic acid 51, ω-deprotection to alcohol 52 and 
then cyclisation gave the desired macrolide 9.  
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Scheme 3.  Preparation of 5,5,8,8-tetrafluorododecanolactone 9. Reagents and conditions: a) IBX, DMSO, rt, 
75% for 39, 78% for 41, 72% for 44, 60% for 46; b) BnO(CH2)2C≡CH, BuLi, THF, -78°C to rt, 83%; c) 
DAST, 50°C, 43% for 42, 75% for 47; d) CAN, CH3CN, H2O, rt, 96% for 43, 77% for 48; e) 
PMBO(CH2)2C≡CH, BuLi, THF, -78°C to rt, 49%; f) triisopropylsilyl chloride, imidazole, DCM, rt, 97%; g) 
H2, 10% Pd/C, THF, 2h, 47%; h) PhI(OAc)2, TEMPO, CH3CN/H2O, 64%; i) HF-pyridine, THF, 50%; j) 2,4,6-
trichlorobenzoyl chloride, Et3N, THF, DMAP, toluene, rt, 50%. 
 
X-Ray structure analysis: Of the five compounds prepared in this study, 6 and 7 were 
colourless oils, 5 and 8 were semi-solids at room temperature and notably 12-dodecanolide 
9, with two CF2 groups, was a crystalline solid. In the event the three lactones 5, 8 and 9 
proved amenable to X-ray analysis and the resultant structures are shown in Figure 1. It is 
clear from these structures that in all cases the CF2 groups occupy corner locations, certainly 
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in the solid state, consistent with our previous conclusions on thermodynamically favoured 
location of the CF2 groups in rings. Compounds 5 and 9 have a common C(5)F2 group and 
they adopt almost identical solid state conformations.  
 
 
Fig. 1 Representations of the X-ray derived structure of 12-dodecanolides 5, 8 and 9. In all 
cases the CF2 groups adopt corner locations in the solid state. 
 
Bioactivity screening: Electroantennogram-detection (EAD) analyses [13] were conducted 
to determine if one or more of the 12-dodecanolides were detectable to adult female A. 
planipennis beetles. Ten adult insects (7-10 days old) were used in the study. All five 12-
dodecanolides 5-9 as well as a hexane (Sigma Aldrich, 99%) control and the female 
pheromone, (3Z)-dodecen-12-olide 2 were used for each antenna. Concentrations of the 12-
fluorine containing dodecanolides 5-9 and pheromone 2 were about 4mM (1mg/ml) with the 
stimulus source concentration for each compound at 3 µg. The order in which the 
compounds were applied to each antenna was randomly assorted for each antennal 
preparation. 
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Fig 2. Electroantennogram-detection (EAD) analyses of 12-dodecanolides 5-9 of the 
antennae of female A. planipennis beetles against hexane and the pheromone, 3Z-lactone 2. 
 
After Log transformation of multiple measurements followed by a one-way ANOVA 
analysis, a post-hoc Tukey HSD test was then applied to compare pairs of compounds, to 
identify which pair-wise comparisons gave significantly different responses. This analysis 
demonstrated significant stimulatory differences for all of the fluorinated 12-decanolides 
relative to the hexane control, with the most significant responses being detected for 
decanolides 7, 8 and 9. Notably there was a significant difference between 12-decanolides 5 
and 9 despite having similar solid state conformations, the latter having an additional CF2 at 
C-8. This difference may indicate a poorer performance for the more conformationally 
flexible decanolide 5. 
 
3. Conclusion 
In this study we have synthesised five 12-decanolides 5-9 each carrying CF2 groups at 
different locations around the macrolide ring. These compounds are new analogues of the 
pheromones of the Emerald Ash Borer, a significant pest in North American and Canadian 
forests. Three of these compounds were amenable to X-ray structure analysis and reinforced 
the hypothesis that the CF2 groups will adopt corner locations in aliphatic ring systems, 
placing limitations on the accessible conformational space in each case.  In the event all of 
the compounds gave a positive EAD response with female EAB beetle antenna, with several 
showing similar levels of stimulatory activity to the natural pheromone, (3Z)-dodecen-12-
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olide 2. Thus the fluorines do not have a significantly negative effect and indeed the 
analogue 9 carrying four fluorines, with two conformationally biasing CF2 groups, recorded 
a similar stimulatory response to pheromone 2. This analogue might have been expected to 
suffer most detrimentally in the context of reduced volatility. The results provide some 
support to the developing hypothesis that correctly biasing conformation, in this case with 
CF2 group, can improve pheromone efficacy.  
 
4. Experimental Section 
 
General procedure for the last step of the synthesis of 12-decanolides 5-9.  Triethylamine 
(15.0 equiv.) and 2,4,6-trichlorobenzoyl chloride (10.0 equiv.) were added to a solution of 
12-hydroxydodecanoic acid bearing CF2 group(s) (17, 32, 33, 37, 52) (1.0 equiv., 2 mM) in 
dry THF at room temperature under an argon atmosphere. The reaction mixture was stirred 
for 2 h and then the mixture was diluted with dry toluene (half volume of THF) and added 
over 2 h using syringe pump to a solution of 4-DMAP (20 equiv., 70 mM) in dry toluene. The 
reaction mixture was stirred at room temperature for 12 h and then quenched with sat. aq. 
NaHCO3 solution and diluted with DCM. The organic layer was separated and the aqueous 
was extracted into DCM. The combined organic layers were washed with brine, dried over 
anhydrous MgSO4 and the solvent was removed under reduced pressure. Purification by 
column chromatography using silica gel (hexanes/EtOAc 15:1) gave the lactones 5-9. 
X-ray diffraction data for 5, 8 and 9  were collected at 173 K using a Rigaku MM-007HF 
High Brilliance RA generator/confocal optics with XtaLAB P100 diffractometer [Cu Kα 
radiation (λ = 1.54187 Å)]. Intensity data were collected using both ω and φ steps 
accumulating area detector images spanning at least a hemisphere of reciprocal space. Data 
for all compounds analysed were collected and processed (including correction for Lorentz, 
polarization and absorption) using CrystalClear [20]. Structures were solved by direct 
methods (SIR2011) [21] and refined by full-matrix least-squares against F2 (SHELXL-
2016/4) [22]. Non-hydrogen atoms were refined anisotropically, and hydrogen atoms were 
refined using a riding model. All calculations were performed using the CrystalStructure [23] 
interface. CCDC 1891108-1891110 contains the supplementary crystallographic data for this 
paper. The data can be obtained free of charge from The Cambridge Crystallographic Data 
Centre via www.ccdc.cam.ac.uk/structures. 
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5,5-Difluorododecanolactone (5). Colourless wax (32%).  1H NMR (400 MHz, CDCl3) δH 
1.38-1.97 (m, 16H, 8 × CH2), 2.40-2.43 (m, 2H, CH2CO), 4.17-4.19 (m, 2H, CH2O); 13C 
NMR (100 MHz, CDCl3) δC 19.1 (t, 3JCF = 5.7 Hz CH2,), 20.8 (t, CH2, 3JCF = 5.7 Hz), 24.6 
(CH2), 25.9 (CH2), 26.5 (CH2), 27.2 (CH2), 33.3 (t, 2JCF = 25.2 Hz, CH2), 34.2 (t, 2JCF = 25.7 
Hz, CH2),  65.5 (CH2O), 125.9 (t, 1JCF = 246.9 Hz, CF2), 172.8 (C=O); 19F{1H} NMR (377 
MHz, CDCl3) δF  -91.2 (s, CF2), 19F NMR (377 MHz, CDCl3) δF -91.2 (p, J = 15.0 Hz, CF2); 
HRMS (ESI+) 257.1322 [M+Na]+, C12H20F2O2Na requires 257.1329.  
 
X. Ray data; C12H20F2O2, M = 234.29, monoclinic, a = 12.188(3), b = 6.4319(10), c = 
16.142(3) Å, β = 106.701(6) °, U = 1212.0(4) Å3, T = 173 K, space group P21/n (no. 14), Z = 
4, 12204 reflections measured, 2185 unique (Rint = 0.0986), which were used in all 
calculations. The final R1 [I > 2σ(I)] was 0.0550 and wR2 (all data) was 0.1402. 
 
6,6-Difluorododecanolactone (6). Colourless oil (44%). 1H NMR (400 MHz, CDCl3) δH 
1.37-1.55 (m, 8H, 4 × CH2), 1.66-1.77 (m, 4H, 2 × CH2), 1.82-1.97 (m, 4H, 2 × CH2CF2), 
2.38-2.41 (m, 2H, CH2CO), 4.16-4.18 (m, 2H, CH2O); 13C NMR (100 MHz, CDCl3) δC 20.2 
(t, 3JCF = 5.6 Hz, CH2), 22.0 (t, 3JCF = 5.6 Hz, CH2), 24.2 (CH2), 24.5 (CH2), 26.6 (CH2), 27.1 
(CH2), 32.7 (t, 2JCF  = 25.3 Hz, CH2),  33.8 (CH2), 34.3 (t, 2JCF  = 25.7 Hz, CH2), 64.9 (CH2O), 
126.4 (t, 1JCF  = 239 Hz, CF2), 173.6 (C=O);  19F{1H} NMR (376 MHz, CDCl3) δF -90.5 (s, 
CF2); 19F NMR (376 MHz, CDCl3) δF -90.5 (p, J = 15.2 Hz, CF2); HRMS (ESI+) 257.1322 
[M+Na]+, C12H20F2O2Na requires 257.1324.  
 
7,7-Difluorododecanolactone (7). Colourless oil (52%). 1H NMR (400 MHz, CDCl3) δH 
1.42-1.59 (m, 8H, 4 × CH2), 1.71-1.77 (m, 4H, 2 × CH2), 1.84-1.97 (m, 4H, 2 × CH2CF2), 
2.41-2.44 (m, 2H, CH2CO), 4.20-4.22 (m, 2H, CH2O); 13C NMR (100 MHz, CDCl3) δC  21.3 
(t, 3JCF = 5.6 Hz, CH2), 21.8 (t, 3JCF = 5.6 Hz, CH2), 23.6 (CH2), 25.8 (CH2), 26.6 (CH2), 27.5 
(CH2), 33.1 (t, 2JCF = 25.3 Hz, CH2), 34.1 (t, 2JCF = 25.7 Hz, CH2), 34.3 (CH2), 65.7 (CH2O), 
126.6 (t, 1JCF  = 240.2 Hz, CF2), 173.8 (C=O); 19F{1H} NMR (376 MHz, CDCl3) δF -89.3 (s, 
CF2); 19F NMR (376 MHz, CDCl3) δF -89.3 (p, J = 15.2 Hz, CF2); HRMS (ESI+) 215.1447 
[M-F]+, C12H20FO2 requires 215.1447.  
 
8,8-Difluorododecanolactone (8). Colourless gum (63%). 1H NMR (400 MHz, CDCl3) δH 
1.39-1.56 (m, 8H, 4 × CH2), 1.69-1.79 (m, 4H, 2 × CH2), 1.82-1.98 (m, 4H, 2 × CH2CF2), 
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2.39-2.42 (m, 2H, CH2CO), 4.19-4.22 (m, 2H, CH2O); 13C NMR (100 MHz, CDCl3) δC  19.2 
(t, 3JCF = 5.7 Hz, CH2), 20.3 (t, 3JCF = 5.5 Hz, CH2), 24.2 (CH2), 26.2 (CH2), 26.3 (CH2), 27.1 
(CH2), 32.5 (t, 2JCF = 25.3 Hz, CH2), 34.3 (t, 2JCF = 25.7 Hz, CH2), 34.6 (CH2), 63.0 (CH2O), 
126.4 (t, 1JCF = 240.2 Hz, CF2), 173.8 (C=O); 19F{1H} NMR (376 MHz, CDCl3) δF -90.8 (s, 
CF2); 19F NMR (376 MHz, CDCl3) δF -90.8 (p, J = 15.2 Hz, CF2); HRMS (ESI+) 215.1439 
[M-F]+, C12H20FO2 requires 215.1447.  
 
X. Ray data; C12H20F2O2, M = 234.29, monoclinic, a = 11.2700(19), b = 8.3223(14), c = 
12.952(2) Å, β = 96.450(4) °, U = 1207.1(3) Å3, T = 173 K, space group P21/n (no. 14), Z = 
4, 11813 reflections measured, 2151 unique (Rint = 0.0730), which were used in all 
calculations. The final R1 [I > 2σ(I)] was 0.0562 and wR2 (all data) was 0.1918. 
 
5,5,8,8-Tetrafluorododecanolactone (9). Colourless solid (50%). 1H NMR (400 MHz, 
CDCl3) δH 1.49-1.57 (m, 2H, CH2), 1.74-1.80 (m, 2H, CH2), 1.84-1.87 (m, 2H, CH2),1.90-
2.11 (m, 8H, 4 × CH2), 2.46 (t, 2H, 3JCF = 5.8 Hz, CH2CO), 4.22 (t, 2H, 3JCF = 5.4 Hz, CH2O); 
δC 19.3 (t, 3JCF = 6.2 Hz, CH2), 19.7 (t, 3JCF = 5.5 Hz, CH2), 27.3 (CH2), 28.4 (tt, 3JCF = 5.5 
Hz, 2JCF = 27.5 Hz, CH2), 28.8 (tt, 3JCF =  5.8 Hz, 2JCF = 27.1 Hz, CH2), 33.8 (t, 2JCF = 26.0 
Hz, CH2), 34.0 (CH2), 33.99 (t, 2JCF = 25.6 Hz, CH2), 64.1 (CH2O), 125.0 (t, 1JCF = 241.2 Hz, 
CF2), 125.1 (t, 1JCF = 241.2 Hz, CF2), 172.2 (C=O); {1H}19F (377 MHz, CDCl3) –92.7 (br s), 
-92.5 (t, 5JF,F  = 1.3 Hz); MS (ESI+) 293.11398 [M+Na]+, C12H18F4O2Na requires 293.1141. 
M.pt 99-103oC. 
 
X. Ray data; C12H18F4O2, M = 270.27, monoclinic, a = 12.2019(12), b = 6.5194(6), c = 
16.2763(15) Å, β = 107.805(2) °, U = 1232.7(2) Å3, T = 173 K, space group P21/n (no. 14), Z 
= 4, 12544 reflections measured, 2219 unique (Rint = 0.0542), which were used in all 
calculations. The final R1 [I > 2σ(I)] was 0.0414 and wR2 (all data) was 0.1103. 
The experimental procedures for the synthesis and analysis of the intermediates/precursors 
can be obtained in the Supplementary Section (Appendix)  
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Appendix Supplementary data 
Supplementary data to this article can be found on line at …. 
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